CRINETICS PHARMACEUTICALS IN

Ticker: CRNX CUSIP: 22663K107 Class: EQTY

Altium Capital Management LP's Holding History (CIK: 0001746382)

Note: Option positions (PUT/CALL) are excluded.

Q4 2023
Shares 65,000 Value ($000) $2,313 Avg Close $30.67 Range $25.35 - $37.88
Q3 2023
Shares 262,000 Value ($000) $7,792 Avg Close $20.61 Range $15.76 - $31.00
Q2 2023
Shares 135,000 Value ($000) $2,433 Avg Close $19.94 Range $15.50 - $24.58
Q1 2023
Shares 100,000 Value ($000) $1,606 Avg Close $18.51 Range $15.23 - $21.65
Q1 2022
Shares 204,000 Value ($000) $4,478 Avg Close $20.24 Range $16.53 - $28.95
Q4 2021
Shares 331,000 Value ($000) $9,404 Avg Close $24.65 Range $18.97 - $28.82
Q3 2021
Shares 193,000 Value ($000) $4,063 Avg Close $20.92 Range $16.68 - $25.50
Q2 2021
Shares 533,033 Value ($000) $10,048 Avg Close $17.57 Range $15.15 - $21.64
Q1 2021
Shares 361,930 Value ($000) $5,530 Avg Close $15.50 Range $13.29 - $18.09
Q4 2020
Shares 361,930 Value ($000) $5,107 Avg Close $13.93 Range $11.61 - $17.84